NEWS

logo.gif (1594 bytes)

NEWS

Press Releases NEWS PAGE COMPANY INDEX Press Releases

 

Novartis
Novartis is a world leader in Life Sciences with core business in Healthcare, Agribusiness and Nutrition. In 1997, Novartis Group sales were 31.2 billion Swiss francs (U.S. $21.6 billion), of
which 18.8 billion (U.S. $13.0 billion) were in Healthcare, 8.3 billion (U.S. $5.8 billion) in Agribusiness and 4.1 billion (U.S. $2.8 billion) in Nutrition. The group annually invests more than 3.6 billion Swiss francs (U.S. $2.5 billion) in R&D. Headquartered in Basel, Switzerland, Novartis employs about 87,000 people and operates in over 100 countries around the world.
September 00

Novartis invites shareholders to vote on Syngenta (3000)

July 00

Novartis Agribusiness: New agricultural technologies for developing countries (2894)

European Commission approves AstraZeneca - Novartis merger (2877)

June 00

Strategic Diagnostics announces development, licensing and distribution agreement with Novartis Seeds (2705)

May 00

Positech breakthrough offers alternative to antibiotic resistance marker genes for genetically enhanced crops (2687)

February 00

Novartis reports 11% rise in net income in 1999 (2507)

December 99

Launch of a global leader in agribusiness - Novartis to focus on healthcare: Novartis and AstraZeneca announce spin-off followed by merger of agribusiness activities (2280)
Lancement d'un leader mondial de l'agribusiness - Novartis se concentre sur la Santé - Novartis et AstraZeneca annoncent un " spin-off " suivi de la fusion de leurs activités agribusiness (2281)

October 99

Novartis' sales reach CHF 24.2 billion in the first nine months of 1999 (2185)

September 99

Novartis outlines new agribusiness strategy (2164)
Novartis stellt neue Agribusiness Strategie vor

August 99

Novartis achieves 5% increase in net income in first half of 1999 (2070)

Novartis launches first "seed-delivered" corn rootworm control (2050)

July 99

Genzyme Molecular Oncology enters agricultural genomics collaborations (1995)

Novartis reports sales of CHF 16.3 billion in first half of 1999 - Focus on growth drivers and rejuvenation of the product portfolio on track (1977)

Novartis acquires majority of Eridania Beghin-Say's seeds activities (1959)
Novartis Seeds acquiert la majorité des activités semencières d'Eridania Beghin-Say

June 99

Novartis announces first steps in new agribusiness strategy - Streamlined organization to focus on top priorities (N1880)
Novartis annonce une première série de mesures pour la nouvelle stratégie de sa Division Agribusiness

Novartis veröffentlicht erste Schritte der neuen Agribusiness-Strategie

May 99

Management changes mark new phase at Novartis. Heinz Imhof takes over as Head of Agribusiness (N1836)

Alliance stratégique de Secobra Recherches et Novartis Seeds SA (N1827)
Strategic alliance between Secobra Recherches and Novartis Seeds SA

April 99

Novartis' First Quarter Sales Reach CHF 7.9 Billion (N1743)

March 99

Novartis net income rises 16% in second year of operations (N1623)

February 99

Novartis announces new herbicide tolerance technology (N1571)

January 99

Novartis reports 1998 Group sales (N1467)

Change at the helm of Novartis (N1443)

DNAP Holding Corporation announces technology agreement with Novartis Seeds (N1424)

December 98

Deferral of ruling: French Conseil d’Etat consults European Court of Justice (N1402)

November 98

Novartis Agricultural Discovery Institute announces unique research agreement with UC Berkeley (N1401)

Agrément de l’Union Européenne pour le maïs Bt-11 de Novartis (N1829)

Alliance strategique de Maisadour et Novartis (N1359)
Strategic alliance between Maisadour and Novartis

October 98

Swiss approval for second Novartis Bt maize (N1358)
Les autorités suisses approuvent le second maïs Bt de Novartis
Zweiter Bt-Mais von Novartis in der Schweiz zugelassen

Bt-Mais: Will Greenpeace Landwirte und Verbraucher entmündigen? (N1830)

September 98

Le Conseil d’Etat suspend la commercialisation des trois variétés de maïs transgéniques de Novartis autorisées en février dernier (N1831)

August 98

Novartis announces $20-million project to expand biotech facility in Research Triangle Park, North Carolina (N1324)

July 98

Novartis announces $600 million investment in agricultural genomics (N1325)

June 98

Novartis Bt-11 corn approved in European Union (N1451)

May 98

Novartis acquires minority interest in C.C. Benoist Companies to form cereal development center in France (N1085)
.

.

 

Copyright © 1998 SeedQuest - All rights reserved